Cargando…
Immune Checkpoint Neuropilins as Novel Biomarkers and Therapeutic Targets for Pancreatic Cancer
SIMPLE SUMMARY: Malignant tumors, especially pancreatic cancer, are the major contributors to cancer mortality worldwide, and their effective treatments are still limited. Our study suggested that NRPs, especially NRP1, are attractive diagnostic and prognostic biomarkers, mediate immunoregulation, a...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136637/ https://www.ncbi.nlm.nih.gov/pubmed/37190154 http://dx.doi.org/10.3390/cancers15082225 |